Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.

Knut BrockowSonja MathesJörg FischerSebastian VolcUlf DarsowBernadette EberleinTilo Biedermann

Published in: Allergy (2021)

Taking a detailed history excluded PEG allergy in most referred patients and enabled direct safe vaccination. Immediate urticaria/anaphylaxis to typical elicitors identified patients requiring PEG allergy workup. Skin tests ± BAT identified PEG allergy and helped to select the vaccine and the vaccination approach. Even PEG-allergic patients can tolerate COVID-19 vaccines.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
drug delivery
coronavirus disease
sars cov
peritoneal dialysis
prognostic factors